AzTrials
AzTrials

Post Operative PainPhase 4NCT05338320

Postoperative Analgesia in Patients Undergoing Elective Lumbar Fusion Operations Under General Anesthesia

A Phase 4 study testing Ultrasound Guided Erector Spinae Plane Block, Intrathecal morphine and General anesthesia using intravenous fentanyl (1µg/kg) in people with Post Operative Pain, run by Ain Shams University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

It was proven that intrathecal opioids are considered as an effective means of pain control in several major surgical interventions including spine surgeries. Intrathecal morphine added to a spinal anesthesia reduces acute pain after spine surgeries but has side effects, including dose dependent respiratory… Read more about this study

Who is it for?
Ages 21 to 55 years
Conditions the study is for
Post Operative Pain
What is being tested?
Ultrasound Guided Erector Spinae Plane Block, Intrathecal morphine and General anesthesia using intravenous fentanyl (1µg/kg)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteEgypt
Study dates
10 May 2022to 30 Sep 2024
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 55 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Body mass index (BMI) 25 to 35 kg/m².
  • American Society of Anesthesiologist (ASA) physical status I or II.

Who cannot join

  • patient's refusal
  • Altered mental status
  • Known allergy to study drugs (bupivacaine or morphine)
  • Local infection at site of puncture.
  • Known case with any pulmonary disease
  • Known case with Obstructive sleep apnea (OSA)
  • Coagulopathy and /or thrombocytopenia
  • Severe hepatic or kidney impairment

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Ain-Shams University Hospitals

    Cairo

Other trials in Egypt

About this study

Official title: A Randomized Controlled Trial for Postoperative Analgesia in Patients Undergoing Elective Lumbar Fusion Operations Under General Anesthesia: Ultrasound Guided Erector Spinae Plane Block Versus Intrathecal Morphine

It was proven that intrathecal opioids are considered as an effective means of pain control in several major surgical interventions including spine surgeries. Intrathecal morphine added to a spinal anesthesia reduces acute pain after spine surgeries but has side effects, including dose dependent respiratory depression, nausea, vomiting, pruritus, and sedation. Ultrasound guided Erector Spinae Plane Block (ESPB) was first described in 2016.Recent case reports suggest a positive effect of ultrasound guided ESPB on pain for multiple indications including lumbar spine fusion and scoliosis surgery, with a very low risk of complications as there are no structures in close proximity at risk of needle injury.

Being tested
Ultrasound Guided Erector Spinae Plane Block, Intrathecal morphine, General anesthesia using intravenous fentanyl (1µg/kg)
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasound Guided Erector Spinae Plane BlockProcedure or surgery

    General anesthesia and Ultrasound Guided Erector Spinae Plane Block

  • Intrathecal morphineDrug

    General anesthesia and intrathecal morphine

  • General anesthesia using intravenous fentanyl (1µg/kg)Other

    General anesthesia using intravenous fentanyl (1µg/kg)

Study groups in NCT05338320
Study groupRoleWhat they receive
General anesthesia and Ultrasound Guided Erector Spinae Plane BlockActive comparatorNot described
Receives: Procedure: Ultrasound Guided Erector Spinae Plane Block
General anesthesia and intrathecal morphineActive comparatorNot described
Receives: Drug: Intrathecal morphine
General anesthesia using intravenous fentanyl (1µg/kg)OtherNot described
Receives: Other: General anesthesia using intravenous fentanyl (1µg/kg)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to first requested rescue analgesia (Minutes).

    Time to first requested rescue analgesia (Minutes).

    Measured: First 24 hours after surgery.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Apr 2022
  2. Study start10 May 2022
  3. Primary completion30 Sep 2024
  4. Study completion30 Sep 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05338320
Sponsor's protocol ID
FMASU MD 102/2022
Status last verified
Oct 2024
First submitted
14 Apr 2022
Last updated
15 Oct 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Ashoor TM, Abdelaal HAS, Elewa GEM, Esmat IM, Rabie AH, Ibrahim AIS, Mohamed AK. Comparison of ultrasound-guided erector spinae plane block to intrathecal morphine for postoperative analgesia in patients undergoing elective lumbar fusion operations under general anesthesia: a randomized controlled trial. BMC Anesthesiol. 2026 Jul 17;26(1):430. doi: 10.1186/s12871-026-04030-4.

    PubMed 42464120

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Ultrasound Guided Erector Spinae Plane Block, Intrathecal morphine and General anesthesia using intravenous fentanyl (1µg/kg) in people with Post Operative Pain, run by Ain Shams University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to first requested rescue analgesia (Minutes). (time frame: First 24 hours after surgery.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05338320, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2024; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in